Khalifa M, Abdelsalam R, Safar M, Zaki H
Inflammopharmacology. 2022; 30(6):2477-2488.
PMID: 35727381
PMC: 9700579.
DOI: 10.1007/s10787-022-01010-1.
Al-Nema M, Gaurav A, Lee V, Gunasekaran B, Lee M, Okechukwu P
RSC Adv. 2022; 12(3):1576-1591.
PMID: 35425186
PMC: 8979230.
DOI: 10.1039/d1ra07649c.
Pang Q, Kim J, Choi J, Song J, Lee S, Cho E
Biomed Res Int. 2022; 2022:4513998.
PMID: 35036433
PMC: 8759886.
DOI: 10.1155/2022/4513998.
Lee H, Kang S, Jeong H, Kwon J, Kim Y, Kim H
Clin Psychopharmacol Neurosci. 2021; 19(4):618-627.
PMID: 34690117
PMC: 8553526.
DOI: 10.9758/cpn.2021.19.4.618.
Angelis D, Savani R, Chalak L
Pediatr Res. 2020; 89(4):738-745.
PMID: 32563183
DOI: 10.1038/s41390-020-1017-0.
Furoxans (Oxadiazole-4 N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory.
Horton A, Nash K, Tackie-Yarboi E, Kostrevski A, Novak A, Raghavan A
J Med Chem. 2018; 61(10):4593-4607.
PMID: 29683322
PMC: 6344890.
DOI: 10.1021/acs.jmedchem.8b00389.
Regucalcin confers resistance to amyloid-β toxicity in neuronally differentiated PC12 cells.
Murata T, Yamaguchi M, Kohno S, Takahashi C, Kakimoto M, Sugimura Y
FEBS Open Bio. 2018; 8(3):349-360.
PMID: 29511612
PMC: 5832982.
DOI: 10.1002/2211-5463.12374.
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease.
Fiorito J, Vendome J, Saeed F, Staniszewski A, Zhang H, Yan S
J Med Chem. 2017; 60(21):8858-8875.
PMID: 28985058
PMC: 9614283.
DOI: 10.1021/acs.jmedchem.7b00979.
Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1.
Morgese M, Colaianna M, Mhillaj E, Zotti M, Schiavone S, DAntonio P
Front Neurosci. 2015; 9:428.
PMID: 26594145
PMC: 4633524.
DOI: 10.3389/fnins.2015.00428.
Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
Luo J, Lee S, VandeVrede L, Qin Z, Piyankarage S, Tavassoli E
BMC Neurosci. 2015; 16:67.
PMID: 26480871
PMC: 4612403.
DOI: 10.1186/s12868-015-0208-9.
Synaptic therapy in Alzheimer's disease: a CREB-centric approach.
Teich A, Nicholls R, Puzzo D, Fiorito J, Purgatorio R, Fa M
Neurotherapeutics. 2015; 12(1):29-41.
PMID: 25575647
PMC: 4322064.
DOI: 10.1007/s13311-014-0327-5.
Role of cyclic nucleotide-gated channels in the modulation of mouse hippocampal neurogenesis.
Podda M, Piacentini R, Barbati S, Mastrodonato A, Puzzo D, DAscenzo M
PLoS One. 2013; 8(8):e73246.
PMID: 23991183
PMC: 3750014.
DOI: 10.1371/journal.pone.0073246.
Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly.
Torregrossa A, Aranke M, Bryan N
J Geriatr Cardiol. 2012; 8(4):230-42.
PMID: 22783310
PMC: 3390088.
DOI: 10.3724/SP.J.1263.2011.00230.
Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy.
Qin Z, Luo J, VandeVrede L, Tavassoli E, Fa M, Teich A
J Med Chem. 2012; 55(15):6784-801.
PMID: 22779770
PMC: 3680370.
DOI: 10.1021/jm300353r.
Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.
Schiefer I, VandeVrede L, Fa M, Arancio O, Thatcher G
J Med Chem. 2012; 55(7):3076-87.
PMID: 22429006
PMC: 3407596.
DOI: 10.1021/jm201504s.
Regulation of IL-1β-induced cyclooxygenase-2 expression by interactions of Aβ peptide, apolipoprotein E and nitric oxide in human neuroglioma.
Samy A, Igwe O
J Mol Neurosci. 2011; 47(3):533-45.
PMID: 22101739
DOI: 10.1007/s12031-011-9670-8.
Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.
Miller T, Isenberg J, Shih H, Wang Y, Roberts D
PLoS One. 2011; 5(12):e15686.
PMID: 21203512
PMC: 3008726.
DOI: 10.1371/journal.pone.0015686.
Pharmacological modulators of nitric oxide signaling and contextual fear conditioning in mice.
Kelley J, Anderson K, Itzhak Y
Psychopharmacology (Berl). 2010; 210(1):65-74.
PMID: 20224887
DOI: 10.1007/s00213-010-1817-8.
Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity.
Counts S, Mufson E
J Neurochem. 2010; 113(3):649-60.
PMID: 20132474
PMC: 2913691.
DOI: 10.1111/j.1471-4159.2010.06622.x.
Impairments in fear conditioning in mice lacking the nNOS gene.
Kelley J, Balda M, Anderson K, Itzhak Y
Learn Mem. 2009; 16(6):371-8.
PMID: 19470653
PMC: 2704101.
DOI: 10.1101/lm.1329209.